← Back to Search

UV Water Treatment

UV Water Treatment for Gastroenteritis in Children (WET Trial)

N/A
Recruiting
Led By Heather M Murphy, PhD
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

WET Trial Summary

This trial will test if household treatment of private well water by ultraviolet light (UV) vs. sham (inactive UV device) decreases the incidence of GI in children under 5.

Who is the study for?
This trial is for children under 5 years old who drink untreated well water and live in specific counties of Pennsylvania. They must be full-time residents at a home served by a private well, and their parent or guardian needs to have texting capabilities on their phone. Children who only drink bottled water, are immunocompromised, have chronic GI conditions, or take daily oral steroids cannot participate.Check my eligibility
What is being tested?
The study aims to see if treating private well water with ultraviolet light (UV) can reduce gastrointestinal illnesses in young children compared to using an inactive UV device. It's the first randomized controlled trial focused on illness from drinking untreated well water.See study design
What are the potential side effects?
Since this trial involves the use of UV devices rather than medication, traditional side effects associated with drugs are not expected. However, there may be unforeseen risks related to participating in any clinical study.

WET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incident gastrointestinal illness
Secondary outcome measures
Acute respiratory infection

WET Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active UV DeviceActive Control1 Intervention
A household water treatment device with a lamp emitting germicidal UV. The device will be operated at 50 millijoule per square centimeter to treat >99.9% of all bacteria, protozoa, and most viruses in water supplies.
Group II: Inactive UV DevicePlacebo Group1 Intervention
A household water treatment device with a lamp not emitting germicidal UV but still emitting light (appears identical to the active UV device).

Find a Location

Who is running the clinical trial?

Temple UniversityLead Sponsor
297 Previous Clinical Trials
82,065 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,270 Previous Clinical Trials
5,484,329 Total Patients Enrolled
Heather M Murphy, PhDPrincipal InvestigatorTemple University

Media Library

Active UV Device (UV Water Treatment) Clinical Trial Eligibility Overview. Trial Name: NCT04826991 — N/A
Waterborne Illnesses Research Study Groups: Active UV Device, Inactive UV Device
Waterborne Illnesses Clinical Trial 2023: Active UV Device Highlights & Side Effects. Trial Name: NCT04826991 — N/A
Active UV Device (UV Water Treatment) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04826991 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the minimum age limit for this clinical experiment below 25 years?

"The minimum and maximum ages for patient enrollment in this experiment are 6 and 59 months, respectively."

Answered by AI

To what demographic is participation in this clinical trial open?

"This medical research is seeking 908 infants and toddlers (under 5 years old) afflicted with waterborne illnesses, residing in the counties of Berks, Bucks, Chester, Lancaster, Lehigh or Montgomery County in Pennsylvania. In addition to these criteria, parental/guardian supervision must have access to a phone with texting capabilities."

Answered by AI

What is the current enrollment of participants in this clinical trial?

"Yes, the information on clinicialtrials.gov confirms that this trial is currently enrolling participants, having first been posted on July 1st 2021 and most recently updated in late July of 2022. The research team seeks to recruit 908 volunteers from a single site."

Answered by AI

Are there any vacancies available for prospective participants in this experiment?

"As per the data provided by clinicaltrials.gov, this trial is presently in a recruitment phase with an initial posting date of July 1st 2021 and last modification on July 29th 2022."

Answered by AI
~257 spots leftby May 2025